Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
DNA synthesis
Biotech
Almirall signs yes-nonsense deal with Eloxx for $3M upfront
Almirall is handing over $3 million for Eloxx Pharmaceuticals’ molecule for a pair of rare skin diseases just before the drug enters the clinic.
James Waldron
Mar 13, 2024 10:31am
Ansa Biotechnologies ties up $68M for DNA synthesis tech
Apr 11, 2022 3:05pm
Takeda teams up with Twist Bioscience to boost biologics R&D
Jul 9, 2020 7:35am
GenScript boosts synthetic biology with CustomArray buy
Dec 27, 2017 2:24pm
George Church, Autodesk embark on project to synthesize the human genome
Jun 6, 2016 5:30am